8B3 Stock Overview
Produces and sells wines in North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
The Duckhorn Portfolio, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.40 |
| 52 Week High | US$10.40 |
| 52 Week Low | US$4.82 |
| Beta | 0.027 |
| 11 Month Change | 2.97% |
| 3 Month Change | 73.33% |
| 1 Year Change | 13.66% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -37.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8B3 | DE Beverage | DE Market | |
|---|---|---|---|
| 7D | 1.0% | -0.5% | -0.4% |
| 1Y | 13.7% | -11.7% | 7.1% |
Return vs Industry: 8B3 exceeded the German Beverage industry which returned -12.8% over the past year.
Return vs Market: 8B3 exceeded the German Market which returned 7.8% over the past year.
Price Volatility
| 8B3 volatility | |
|---|---|
| 8B3 Average Weekly Movement | 29.0% |
| Beverage Industry Average Movement | 3.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8B3's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8B3's weekly volatility has increased from 15% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 573 | Deirdre Mahlan | www.duckhornportfolio.com |
The Duckhorn Portfolio, Inc. produces and sells wines in North America. The company offers wines under a portfolio of brands, including Duckhorn Vineyards, Decoy, Goldeneye, Paraduxx, Migration, Sonoma-Cutrer, Canvasback, Calera, Kosta Browne, Greenwing, and Postmark. It sells wines to distributors, and directly to retail accounts and consumers.
The Duckhorn Portfolio, Inc. Fundamentals Summary
| 8B3 fundamental statistics | |
|---|---|
| Market cap | €1.54b |
| Earnings (TTM) | €53.15m |
| Revenue (TTM) | €384.72m |
29.1x
P/E Ratio4.0x
P/S RatioIs 8B3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8B3 income statement (TTM) | |
|---|---|
| Revenue | US$405.48m |
| Cost of Revenue | US$185.27m |
| Gross Profit | US$220.22m |
| Other Expenses | US$164.20m |
| Earnings | US$56.01m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 54.31% |
| Net Profit Margin | 13.81% |
| Debt/Equity Ratio | 24.5% |
How did 8B3 perform over the long term?
See historical performance and comparison